CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 TGD.US 1 out of 5 Outperform 5Y $1.70 $1.25 (-0.79%) -28.24% +5.31% -33.55
17/03/2014 FNV.US 3 out of 5 Outperform 5Y $52.01 $52.05 (-0.38%) -0.35% +5.31% -5.66
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $1.34 (+2.29%) -32.99% +5.31% -38.30
17/03/2014 GDXJ.US 3 out of 5 Outperform 5Y $44.33 $30.16 (-2.99%) -32.12% +5.31% -37.44
17/03/2014 AEM.US 4 out of 5 Outperform 5Y $34.20 $28.54 (-0.94%) -17.00% +5.31% -22.31
17/03/2014 ANV.US 2 out of 5 Outperform 5Y $6.37 $2.32 (-1.28%) -63.27% +5.31% -68.58
17/03/2014 GG.US 3 out of 5 Outperform 5Y $28.12 $22.08 (-0.96%) -21.65% +5.31% -26.97
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $313.75 (+0.25%) +75.03% +42.31% -32.71
26/02/2013 EXK.US 4 out of 5 Outperform 5Y $6.21 $3.72 (-3.38%) -40.82% +30.54% -71.36
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $4.26 (-6.99%) -3.69% +28.81% -32.50
11/02/2013 PAAS.US 3 out of 5 Outperform 5Y $16.32 $10.44 (+1.66%) -36.38% +28.81% -65.18
05/02/2013 RIC.US 2 out of 5 Outperform 5Y $3.20 $2.53 (-0.40%) -21.09% +30.00% -51.09
05/02/2013 AXU.US 4 out of 5 Outperform 5Y $4.58 $0.50 (-2.47%) -89.14% +30.00% -119.13
04/02/2013 SSRI.US 4 out of 5 Outperform 5Y $12.09 $5.22 (-3.51%) -56.51% +30.02% -86.53
04/02/2013 GORO.US 1 out of 5 Outperform 5Y $12.60 $4.71 (+0.43%) -62.55% +30.02% -92.58
24/01/2013 SGSVF.US 2 out of 5 Outperform 5Y $2.51 $0.41 (-4.53%) -83.47% +31.04% -114.52
23/01/2013 NRT.US 4 out of 5 Outperform 1Y $21.76 $19.24 (-1.85%) -10.10% +31.06% -41.16
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $6.38 (+6.88%) +20.69% +31.06% -10.37
23/01/2013 POT.US 4 out of 5 Outperform 5Y $38.90 $32.71 (-0.21%) -16.11% +31.06% -47.17
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $2.28 (-1.72%) -78.64% +33.06% -111.70
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.